Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions
oleh: Michela Gravina, Lorenzo Spirito, Giuseppe Celentano, Marco Capece, Massimiliano Creta, Gianluigi Califano, Claudia CollĂ Ruvolo, Simone Morra, Massimo Imbriaco, Francesco Di Bello, Antonio Sciuto, Renato Cuocolo, Luigi Napolitano, Roberto La Rocca, Vincenzo Mirone, Carlo Sansone, Nicola Longo
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2022-06-01 |
Deskripsi
The Prostate Imaging Reporting and Data System (PI-RADS) classification is based on a scale of values from 1 to 5. The value is assigned according to the probability that a finding is a malignant tumor (prostate carcinoma) and is calculated by evaluating the signal behavior in morphological, diffusion, and post-contrastographic sequences. A PI-RADS score of 3 is recognized as the equivocal likelihood of clinically significant prostate cancer, making its diagnosis very challenging. While PI-RADS values of 4 and 5 make biopsy necessary, it is very hard to establish whether to perform a biopsy or not in patients with a PI-RADS score 3. In recent years, machine learning algorithms have been proposed for a wide range of applications in medical fields, thanks to their ability to extract hidden information and to learn from a set of data without previous specific programming. In this paper, we evaluate machine learning approaches in detecting prostate cancer in patients with PI-RADS score 3 lesions via considering clinical-radiological characteristics. A total of 109 patients were included in this study. We collected data on body mass index (BMI), location of suspicious PI-RADS 3 lesions, serum prostate-specific antigen (PSA) level, prostate volume, PSA density, and histopathology results. The implemented classifiers exploit a patient’s clinical and radiological information to generate a probability of malignancy that could help the physicians in diagnostic decisions, including the need for a biopsy.